Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of

Eduard Quintana1, Anna Sabate-Rotes2, Joseph J Maleszewski3

  • 1Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn; Servei de Cirurgia Cardiovascular, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.

Insights

Prior alcohol septal ablation before septal myectomy increases risks for hypertrophic obstructive cardiomyopathy patients. This includes higher rates of cardiac death, heart failure, and defibrillator use, suggesting myectomy alone is preferred.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart muscle disease.
  • Septal reduction therapy aims to relieve left ventricular outflow tract obstruction.
  • Alcohol septal ablation and surgical septal myectomy are primary treatments for HOCM.

Purpose of the Study:

  • To evaluate the impact of prior alcohol septal ablation on outcomes of subsequent septal myectomy in HOCM patients.
  • To compare clinical and histopathological findings between patients who underwent septal myectomy after alcohol septal ablation versus primary septal myectomy.

Main Methods:

  • A retrospective matched case-control study comparing 31 patients with prior alcohol septal ablation and septal myectomy to 62 control patients who underwent septal myectomy only.
  • Outcomes assessed included cardiac death, advanced heart failure, implantable cardioverter-defibrillator (ICD) discharge, and surgical results.
  • Preoperative echocardiography, Holter monitoring, and postoperative pathology were analyzed.

Main Results:

  • Patients with prior alcohol septal ablation showed increased preoperative diastolic dysfunction, higher rates of ICD implantation (32% vs. 11%), and more arrhythmias (43% vs. 13%).
  • Postoperative complete heart block was significantly higher (19.4% vs. 1.6%) in the prior ablation group, with two early deaths.
  • Histopathology revealed greater interstitial and endocardial fibrosis in patients with prior alcohol septal ablation.

Conclusions:

  • Prior alcohol septal ablation may increase risks for HOCM patients undergoing septal myectomy, including cardiac death, advanced heart failure, and ICD discharges.
  • These findings support septal myectomy as the preferred initial treatment for septal reduction therapy in HOCM.
  • Avoiding alcohol septal ablation may prevent scarring and diastolic dysfunction, leading to better long-term outcomes.
Abstract